Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC
21 June 2017 - 9:00PM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH / TSX:AUP) (“Aurinia”
or the “Company”) today announced that the Company will be hosting
its Annual General Meeting of Shareholders at 9 a.m. (Pacific Time)
in Vancouver, BC.
An audio webcast can be accessed under "News/Events” through the
“Investors” section of the Aurinia corporate website at
www.auriniapharma.com. A replay of the webcast will be available on
Aurinia’s website.
About Aurinia
Aurinia is a clinical stage biopharmaceutical company focused on
developing and commercializing therapies to treat targeted patient
populations that are suffering from serious diseases with a high
unmet medical need. The Company is currently developing
voclosporin, an investigational drug, for the treatment of LN. The
Company is headquartered in Victoria, BC and focuses its
development efforts globally. www.auriniapharma.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170621005507/en/
Aurinia Pharmaceuticals Inc.Investors:Celia
EconomidesVice President, Public
Affairsceconomides@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2024 to May 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From May 2023 to May 2024